GENE ONLINE|News &
Opinion
Blog

Obesity
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
Obesity Hope or Hype: Leveraging the Efficacy of Mainstream Weight Loss Pills (Second Part)
2024-03-07
Obesity Hope or Hype: Leveraging the Efficacy of Mainstream Weight Loss Pills (First Part)
2024-02-15
Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity
2024-02-07
Semaglutide-Based Medications, Ozempic and Wegovy, Show Lower Suicidal Ideation Risk
2024-01-17
JPM 2024: Pfizer’s Strategic Moves in the Obesity Drug Market and BioNTech’s Oncology Pipeline Expansion
2024-01-10
New Research Links High-Sugar Diets and Obesity to Neurodegenerative Disorders
2023-11-14
Decoding Overweight and Obesity: The Significance of Brain Structure
2023-08-24
Novo Nordisk Delivers Strong H1 Financial Performance, With Acquisition to Expand Weight Loss Market
2023-08-16
Lilly’s Oral GLP-1 Agonist Shows Encouraging Results for Weight Management
2023-06-28
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
EMA Upholds Recommendation For Withdrawing Marketing Authorization for Amfepramone Obesity Medicines
2022-10-28
1 2
LATEST
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
TCELS’s Path to a Self-Sufficient Biotech Thailand: Entrepreneurs in Global Competitiveness, Raw Material Exports, and Cosmetic Innovations
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
Eyes on Nvidia: A Strong Investment Prospect, Driving Billions in AI Development and Advanced Infrastructure
2024-09-30
Immunai and AstraZeneca’s $18 Million AI Collaboration to Transform Cancer Drug Development
2024-09-26
Pfizer Pulls Sickle Cell Treatment Over Deadly Complication Risks
2024-09-26
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top